| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 12/25/2001 | US6333171 CD4 gene regulatory sequences specifically expressed in mature T cells |
| 12/25/2001 | US6333168 Cloning, expression and uses of dorsalin-1 |
| 12/25/2001 | US6333161 Assaying a test ligands ability to bind a central nervous system receptor by incubation the ligand with mutant cells that produce a kainate-binding excitatory amino acid receptor and determining the extent of binding |
| 12/25/2001 | US6333159 Amplifying nucleic acids by separating and denaturing the intrastrand, treating the single strands with primers so that the product is synthesized using a mutated dna polymerase with reduced activity at 25 degrees celsuis |
| 12/25/2001 | US6333030 Chimeric retrovirus/adenovirus system |
| 12/25/2001 | US6333028 Administering autologous human ovarian carcinoma tumor cells conjugated with hapten, wherein the tumor cells have been treated to not grow and divide after administration to a subject |
| 12/25/2001 | CA1341328C Sex-associated membrane proteins and methods for increasing the probability that offspring will be of a desired sex |
| 12/20/2001 | WO2001096875A2 Hcv antigen/antibody combination assay |
| 12/20/2001 | WO2001096870A2 Immunoassays for anti-hcv antibodies |
| 12/20/2001 | WO2001096866A1 Toxicity typing using liver stem cells |
| 12/20/2001 | WO2001096610A1 Hiv-1 reporter viruses and their use in assaying anti-viral compounds |
| 12/20/2001 | WO2001096593A2 Novel motor proteins and methods for their use |
| 12/20/2001 | WO2001096585A2 Modulation of abscisic acid signal transduction in plants |
| 12/20/2001 | WO2001096580A2 Method for modifying plant morphology, biochemistry and physiology using cytokinin oxidases |
| 12/20/2001 | WO2001096574A1 Novel enzyme gene and its expression product |
| 12/20/2001 | WO2001096566A1 Gasc1 gene |
| 12/20/2001 | WO2001096565A2 Binding agents: chimeric ligand/receptor proteins |
| 12/20/2001 | WO2001096563A1 Scramblase 2 |
| 12/20/2001 | WO2001096562A1 Thyrotropin-releasing hormone receptor-like gpcr (gprfwki) |
| 12/20/2001 | WO2001096558A1 Polyfunctional base sequence and artificial gene containing the same |
| 12/20/2001 | WO2001096557A2 A human homologue of the dbf4/ask1 protein, nucleic acids, and methods related to the same |
| 12/20/2001 | WO2001096549A1 Genes for s-adenosyl l-methionine: jasmonic acid carboxyl methyltransferase and a method for the development of pathogen- and stress-resistant plants using the genes |
| 12/20/2001 | WO2001096547A2 Human kinases |
| 12/20/2001 | WO2001096546A2 Protein phosphatases |
| 12/20/2001 | WO2001096533A1 Monkey-origin embryonic stem cells |
| 12/20/2001 | WO2001096532A2 Method of generating pluripotent mammalian cells by fusion of a cytoplast fragment with a karyoplast |
| 12/20/2001 | WO2001096523A2 Polynucleotides related to colon cancer |
| 12/20/2001 | WO2001096393A2 Nucleotide and amino acid sequences of oocyte factors for altering ovarian follicular growth in vivo or in vitro |
| 12/20/2001 | WO2001096390A2 Compositions and methods for the therapy and diagnosis of colon cancer |
| 12/20/2001 | WO2001096388A2 Compositions and methods for the therapy and diagnosis of colon cancer |
| 12/20/2001 | WO2001096385A1 Codon optimised recombinant dermaphagoides allergens |
| 12/20/2001 | WO2001096377A2 Vaccine for congenital tremors in pigs |
| 12/20/2001 | WO2001096376A2 Pro-apoptotic fragments of the dengue virus envelope glycoproteins |
| 12/20/2001 | WO2001096361A1 Method of controlling the binding of calmyrin to presenilin |
| 12/20/2001 | WO2001096360A1 Antisense modulation of c/ebp beta expression |
| 12/20/2001 | WO2001095919A2 A recombinant non-replicating virus expressing gm-csf and uses thereof to enhance immune responses |
| 12/20/2001 | WO2001095861A2 Transdifferentiation of glial cells |
| 12/20/2001 | WO2001095815A1 Integrated herd management system utilizing isolated populations of x-chromosome bearing and y-chromosome bearing spermatozoa |
| 12/20/2001 | WO2001095716A2 High temperature cryogenic preservation of biologically active material |
| 12/20/2001 | WO2001095711A2 Transgenic mice containing nuclear hormone receptor gene disruptions |
| 12/20/2001 | WO2001095709A1 Mouse showing neurofibril change due to senile dementia |
| 12/20/2001 | WO2001095701A2 Methods for somatic embryo formation and plant regeneration of beta vulgaris |
| 12/20/2001 | WO2001088108A8 Neuronal serine-threonine protein kinase |
| 12/20/2001 | WO2001062207A3 Method for treating inflammatory bowel disease and other forms of gastrointestinal inflammation |
| 12/20/2001 | WO2001059100A3 Inhibitor of hepatocyte growth factor activator for use in modulation of angiogenesis and cardiovascularization |
| 12/20/2001 | WO2001055306A3 Nucleic acids, proteins, and antibodies |
| 12/20/2001 | WO2001051006A3 Cardiac-cell specific enhancer elements and uses thereof |
| 12/20/2001 | WO2001049821A3 Th1 specific cd4 t cell lines and method for inducing them ex vivo |
| 12/20/2001 | WO2001046456A3 Biological sensor |
| 12/20/2001 | WO2001046389A3 Immature autologous clinical grade dendritic cells intended for vaccination of cancer patients |
| 12/20/2001 | WO2001044454A3 Root-specific promoter |
| 12/20/2001 | WO2001031016A3 Processed human chemokines phc-1 and phc-2 |
| 12/20/2001 | WO2001029207A8 Antiuracil monoclonal antibody |
| 12/20/2001 | WO2001023592A3 Methods for making recombinant proteins using apoptosis inhibitors |
| 12/20/2001 | WO2001002552A3 Double transgenic animals as models for neurodegenerative disease |
| 12/20/2001 | WO2000073432A3 Activation of dendritic cells to enhance immunity |
| 12/20/2001 | WO2000068387A3 Nucleic acids and proteins with interferon-beta activity |
| 12/20/2001 | WO2000060076A3 Compositions for the treatment and diagnosis of breast cancer and methods for their use |
| 12/20/2001 | WO2000058358A9 49 human secreted proteins |
| 12/20/2001 | WO2000024765A8 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 12/20/2001 | WO2000008133A9 NOVEL G PROTEIN-COUPLED RECEPTOR cDNA SEQUENCE |
| 12/20/2001 | WO1997012960A3 Solid support for use in cell cultivation, especially for the cultivation of liver cells, biological reactor containing said solid support and the use thereof in a bio-artificial liver system |
| 12/20/2001 | WO1995026406A3 Riboflavin synthesis in fungi |
| 12/20/2001 | US20010054186 An improved efficiency agrobacterium-mediated plant transformation method |
| 12/20/2001 | US20010053844 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 12/20/2001 | US20010053769 Use of pro-apoptotic factors in treatment of atherosclerosis |
| 12/20/2001 | US20010053766 Administering a compound such as arginine-glycine-aspartic acid tripeptide that inhibits the interaction between integrin receptor and extracellular matrix to treat glaucoma or elevated intraocular pressure; drug screening |
| 12/20/2001 | US20010053765 Methods and compositions for the selective regulation of chorionic prostanoids |
| 12/20/2001 | US20010053547 Method for preparing a platelet composition |
| 12/20/2001 | US20010053544 Polyhydroxyalkanoate synthase and gene encoding the same enzyme |
| 12/20/2001 | US20010053538 Biologically active synthetic thyrotropin and cloned gene for producing same |
| 12/20/2001 | US20010053536 cDNA clone HDPBI30 that encodes a novel human 7-transmembrane receptor |
| 12/20/2001 | US20010053361 Immunotherapy involving cd28 stimulation |
| 12/20/2001 | US20010053360 Antibody binds an epitope on the HLA-DR polypeptide and induces apoptosis in cells expressing HLA-DR, without concomitant suppression of HLA-DR dependent immune responses. |
| 12/20/2001 | US20010053358 Growth differentiation factor-11 |
| 12/20/2001 | US20010053355 Treated monocytes incubated to maximize number of functional dendritic cells; then incubated with disease effector agents to enhance the presentation of at least one disease-causing antigen expressed by the disease effector agents. |
| 12/20/2001 | US20010053354 Porcine cardiomyocytes and their use in treatment of insufficient cardiac function |
| 12/20/2001 | US20010053353 Injectable polysaccharide-cell compositions |
| 12/20/2001 | US20010053352 Adenovirus vectors containing cell status-specific response elements and methods of use thereof |
| 12/20/2001 | DE10037844C1 Insulated sealing system for bearing traffic, used e.g. on concrete deckings, includes a damping layer on cast asphalt over a bituminous sealing layer |
| 12/20/2001 | DE10027383A1 Nukleinsäure-Molekül umfassend eine für ein Chemokin, einen Neuropeptid-Präkursor oder mindestens ein Neuropeptid kodierende Nukleinsäuresequenz Nucleic acid molecule comprising a sequence coding for a chemokine, a neuropeptide precursor or at least one neuropeptide nucleic acid sequence |
| 12/20/2001 | DE10024171A1 Neuronale Serin-Threonin-Protein-Kinase Neuronal serine threonine protein kinase |
| 12/20/2001 | CA2804117A1 Method for modifying plant morphology, biochemistry and physiology |
| 12/20/2001 | CA2736957A1 Pleiotrophin growth factor receptor for the treatment of proliferative, vascular and neurological disorders |
| 12/20/2001 | CA2413013A1 Novel motor proteins and methods for their use |
| 12/20/2001 | CA2413003A1 Immunoassays for anti-hcv antibodies |
| 12/20/2001 | CA2412902A1 Genes for s-adenosyl l-methionine: jasmonic acid carboxyl methyltransferase and a method for the development of pathogen- and stress-resistant plants using the genes |
| 12/20/2001 | CA2412665A1 Scramblase 2 |
| 12/20/2001 | CA2412663A1 A human homologue of the dbf4/ask1 protein, nucleic acids, and methods related to the same |
| 12/20/2001 | CA2412521A1 Thyrotropin-releasing hormone receptor-like gpcr (gprfwki) |
| 12/20/2001 | CA2412457A1 Modulation of abscisic acid signal transduction in plants |
| 12/20/2001 | CA2412257A1 Pro-apoptotic fragments of the dengue virus envelope glycoproteins |
| 12/20/2001 | CA2412223A1 Compositions and methods for the therapy and diagnosis of colon cancer |
| 12/20/2001 | CA2412217A1 Hiv-1 reporter viruses and their use in assaying anti-viral compounds |
| 12/20/2001 | CA2411462A1 Integrated herd management system utilizing isolated populations of x-chromosome bearing and y-chromosome bearing spermatozoa |
| 12/20/2001 | CA2411278A1 Compositions and methods for the therapy and diagnosis of colon cancer |
| 12/20/2001 | CA2411231A1 Codon optimised recombinant dermaphagoides allergens |
| 12/20/2001 | CA2410896A1 High temperature cryogenic preservation of biologically active material |
| 12/20/2001 | CA2410659A1 Transgenic mice containing nuclear hormone receptor gene disruptions |
| 12/20/2001 | CA2410610A1 Human kinases |